BBB-022

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBBB-022
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic-AMP phosphodiesterases inhibitors
Targets3',5'-cyclic-AMP phosphodiesterases
Therapy Area/IndicationsIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsIschemia

Other Information

ATC CodeN/A
Related LinksN/A